Clinical and genetic characteristics of new allele variants of the Mowat–Wilson syndrome caused by ZEB2 gene mutations
https://doi.org/10.17650/2222-8721-2018-8-3-28-33
Abstract
To date, a large number of monogenic diseases and syndromes, in the clinical picture of which there are convulsions, a psycho-speech development delay and dysmorphic features have been described. One of the hereditary syndromes with a specific phenotype is the Movat–Wilson syndrome. To diagnose the syndrome, a set of survey methods was used: genealogical analysis, neurological examination, evaluation of intellectual development with the help of psychological tests, and sequencing of the new generation exome. As a result of sequencing exome on the panel of genes responsible for the emergence of hereditary epilepsy, two patients of different sex at the age of 10 and 5 years were identified with previously not described mutations in the ZEB2 gene in the heterozygous state. Clinical manifestations of the disease in these patients were of varying degrees of severity, which can be explained in terms of the functional significance of the changes detected. The variety of clinical manifestations of the same disease leads to considerable difficulties in diagnosing, however, due to the introduction of the nextgeneration sequencing in medical practice, the effectiveness of diagnosing hereditary diseases and syndromes, the verification of which has been difficult for a long time, has increased significantly.
About the Authors
I. A. Akimova
Research Centre of Medical Genetics.
Russian Federation
1 Moskvorech’e St., Moscow 115478.
Russian Federation
1 Moskvorech’e St., Moscow 115478.
T. V. Markova
Research Centre of Medical Genetics.
Russian Federation
1 Moskvorech’e St., Moscow 115478.
Russian Federation
1 Moskvorech’e St., Moscow 115478.
F. A. Konovalov
Genomed.
Russian Federation
Build. 5, 8 Podol’skое Shosse, Moscow 115093.
Russian Federation
Build. 5, 8 Podol’skое Shosse, Moscow 115093.
A. V. Antonets
Genomed.
Russian Federation
Build. 5, 8 Podol’skое Shosse, Moscow 115093.
Russian Federation
Build. 5, 8 Podol’skое Shosse, Moscow 115093.
E. L. Dadali
Research Centre of Medical Genetics.
Russian Federation
1 Moskvorech’e St., Moscow 115478.
Russian Federation
1 Moskvorech’e St., Moscow 115478.
References
1. Mowat D. R., Croaker G. D., Cass D. T. et al. Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23. J Med Genet 1998;35(8):617–23. DOI: 10.1136/jmg.35.8.617. PMID: 9719364.
2. Amiel J., Espinosa-Parrilla Y., Steffann J. et al. Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am J Hum Genet 2001;69(6):1370–7. DOI: 10.1086/ 324342. PMID: 11595972. Cacheux V., Dastot-Le Moal F., Kaariainen H. et al. Loss-of-function mutations in SIP1 Smad interacting protein 1 result in a syndromic Hirschsprung disease. Hum Molec Genet 2001;10:1503–10. DOI: 10.1093/ hmg/10.14.1503. PMID: 11448942.
3. Wakamatsu N., Yamada Y., Yamada K. et al. Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nature Genet 2001;27(4):369–70. DOI: 10.1038/86860. PMID: 11279515.
4. Yamada K., Yamada Y., Nomura N. et al. Nonsense and frameshift mutations in ZFHX1B, encoding Smad-interacting protein 1, cause a complex developmental disorder with a great variety of clinical features. Am J Hum Genet 2001;69(6): 1178–85. DOI: 10.1016/j.eplepsyres. 2007.09.006. PMID: 11592033.
5. Moore S. W., Fieggen K., Honey E., Zaahl M. Novel ZEB2 gene variation in the Mowat – Wilson syndrome (MWS). J Pediatr Surg 2016;51 (2):268–71. DOI: 10.1016/j.jpedsurg.2015.10.070. PMID: 26852091.
6. Garavelli L., Mainardi P. C. Mowat – Wilson syndrome. Orphanet J Rare Dis 2007;2:42. DOI: 10.1186/1750-1172-2-42. PMID: 17958891.
7. Wilson M., Mowat D., Dastot-Le Moal F. et al. Further delineation of the phenotype associated with heterozygous mutations in the ZFHX1B. Am J Med Genet 2003;119A (3):257–65. DOI: 10.1002/ ajmg.a.20053. PMID: 12784289.
8. Rehm H.L., Bale S.J., Bayrak-Toydemir P. et al. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 2013;15(9):733–47. DOI: 10.1038/ gim. 2013.92. PMID: 23887774.
9. Zweier C., Horn D., Kraus C., Rauch A. Atypical ZFHX1B mutation associated with a mild Mowat–Wilson syndrome phenotype. Am J Med Genet 2006;140A(8):869–72. DOI: 10.1002/ ajmg.a.31196. PMID: 16532472.
10. Dastot-Le Moal F., Wilson M., Mowat D. et al. ZFHX1B mutations in patients with Mowat – Wilson syndrome. Hum Mutat 2007;28(4):313–21. DOI: 10.1002/ humu.20452. PMID: 17203459.
11. Nitta K. R., Takahashi S., Haramoto Y. et al. The N-terminus zinc finger domain of Xenopus SIP1 is important for neural induction, but not for suppression of Xbra expression. Int J Dev Biol 2007;51(4):321–5. DOI: 10.1387/ ijdb.062252kn. PMID: 17554684.
12. Zweier C., Temple I. K., Beemer F. et al. Characterisation of deletions of the ZFHX1B region and genotype-phenotype analysis in Mowat – Wilson syndrome. J Med Genet 2003;40(8):601–5. DOI: 10.1136/jmg.40.8.601. PMID: 12920073.
Review
For citations:
Akimova I.A., Markova T.V., Konovalov F.A., Antonets A.V., Dadali E.L. Clinical and genetic characteristics of new allele variants of the Mowat–Wilson syndrome caused by ZEB2 gene mutations. Neuromuscular Diseases. 2018;8(3):28-33. (In Russ.) https://doi.org/10.17650/2222-8721-2018-8-3-28-33
Views:
1648
Email this article 